Photodynamic Therapy Using Topical Aminolevulinic Acid in Treating Patients With Actinic Keratosis
A Pilot Study to Investigate the Use of Topical Levulan® With Vbeam® Laser for the Treatment of Actinic Keratoses
Sponsor: National Cancer Institute (NCI)
Terminated
Withdrawn due to low accrual
Other terminated trials from National Cancer Institute (NCI)
Other Precancerous/Nonmalignant Condition trials with similar outcome
A NA clinical study on Precancerous/Nonmalignant Condition, this trial is terminated or withdrawn. The trial is conducted by National Cancer Institute (NCI) and has accumulated 7 data snapshots since 2005. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Dec 2021 — Jul 2024 [monthly]
Terminated NA
-
Jan 2021 — Dec 2021 [monthly]
Terminated NA
-
Jun 2018 — Jan 2021 [monthly]
Terminated NA
▶ Show 2 earlier versions
-
Jul 2017 — Jun 2018 [monthly]
Terminated NA
-
Jan 2017 — Jul 2017 [monthly]
Terminated NA
First recorded
May 2005
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Cancer Institute (NCI)
- Roswell Park Cancer Institute
For direct contact, visit the study record on ClinicalTrials.gov .